|
US7741A
(en)
|
|
1850-10-29 |
|
Cak-cottpling |
|
US347A
(en)
|
|
1837-08-08 |
|
dixon |
|
US5807876A
(en)
|
1996-04-23 |
1998-09-15 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of IMPDH enzyme
|
|
US6054472A
(en)
|
1996-04-23 |
2000-04-25 |
Vertex Pharmaceuticals, Incorporated |
Inhibitors of IMPDH enzyme
|
|
ATE346085T1
(de)
|
1996-12-06 |
2006-12-15 |
Vertex Pharma |
Inhibitoren des interleukin-1-beta konvertierenden enzyms
|
|
EA004141B1
(ru)
|
1999-03-19 |
2004-02-26 |
Вертекс Фармасьютикалз Инкорпорейтед |
Ингибиторы фермента impdh
|
|
US6448281B1
(en)
|
2000-07-06 |
2002-09-10 |
Boehringer Ingelheim (Canada) Ltd. |
Viral polymerase inhibitors
|
|
SV2003000617A
(es)
|
2000-08-31 |
2003-01-13 |
Lilly Co Eli |
Inhibidores de la proteasa peptidomimetica ref. x-14912m
|
|
EP1256628A3
(en)
|
2001-05-10 |
2003-03-19 |
Agouron Pharmaceuticals, Inc. |
Hepatitis c virus (hcv) ns5b rna polymerase and mutants thereof
|
|
OA12622A
(en)
|
2001-06-11 |
2006-06-12 |
Shire Biochem Inc |
Thiophene derivatives as antiviral agents for flavivirus infection.
|
|
CA2449999C
(en)
|
2001-06-11 |
2012-07-31 |
Shire Biochem Inc. |
Compounds and methods for the treatment or prevention of flavivirus infections
|
|
AR035543A1
(es)
|
2001-06-26 |
2004-06-16 |
Japan Tobacco Inc |
Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con
|
|
WO2003007945A1
(en)
|
2001-07-20 |
2003-01-30 |
Boehringer Ingelheim (Canada) Ltd. |
Viral polymerase inhibitors
|
|
EP2335700A1
(en)
|
2001-07-25 |
2011-06-22 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis C virus polymerase inhibitors with a heterobicylic structure
|
|
ES2289161T3
(es)
|
2001-11-02 |
2008-02-01 |
Glaxo Group Limited |
Derivados de 4-(heteroaril de 6 miembros)-acil pirrolidina como inhibidores de hcv.
|
|
MXPA05004608A
(es)
*
|
2002-11-01 |
2005-09-20 |
Viropharma Inc |
Compuestos de benzofurano, composiciones y metodos para tratamiento de profilaxis de infecciones virales de hepatitis c y enfermedades asociadas.
|
|
DK1625154T3
(da)
*
|
2003-05-09 |
2014-02-24 |
Boehringer Ingelheim Int |
Hepatitis c virus ns5b-polymeraseinhibitor-bindende lomme
|
|
DE602005019979D1
(en)
|
2004-01-30 |
2010-04-29 |
Medivir Ab |
Hcv ns-3 serine protease inhibitoren
|
|
WO2005112640A2
(en)
|
2004-05-13 |
2005-12-01 |
Viropharma Incorporated |
Compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
|
|
EP1771169A1
(en)
|
2004-07-14 |
2007-04-11 |
PTC Therapeutics, Inc. |
Methods for treating hepatitis c
|
|
US7868037B2
(en)
|
2004-07-14 |
2011-01-11 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
|
US7781478B2
(en)
|
2004-07-14 |
2010-08-24 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
|
US7772271B2
(en)
|
2004-07-14 |
2010-08-10 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
|
CA2618682C
(en)
*
|
2005-08-12 |
2011-06-21 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
|
US20070265335A1
(en)
|
2005-11-10 |
2007-11-15 |
Wyeth |
Polymorphs of 5-cyclopropyl-2-(4-fluorophenyl)-6-[(2-hydroxyethyl)(methylsufonyl)amino]-n-methyl-1-benzofuran-3-carboxamide and methods of making the same
|
|
KR20090012345A
(ko)
|
2006-05-30 |
2009-02-03 |
애로우 쎄라퓨틱스 리미티드 |
바이페닐 유도체, 및 ｃ형 간염 치료에 있어서의 이들의 용도
|
|
GB0614940D0
(en)
|
2006-07-27 |
2006-09-06 |
Arternis Intelligent Power Ltd |
Vehicle traction and stability control system employing control of fluid quanta
|
|
US8329159B2
(en)
|
2006-08-11 |
2012-12-11 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US7659270B2
(en)
|
2006-08-11 |
2010-02-09 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US7759495B2
(en)
|
2006-08-11 |
2010-07-20 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US8303944B2
(en)
|
2006-08-11 |
2012-11-06 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US20080275032A1
(en)
|
2006-12-29 |
2008-11-06 |
Yuefen Zhou |
Pyridazinone compounds
|
|
EP2134683A2
(en)
|
2007-02-12 |
2009-12-23 |
Intermune, Inc. |
Novel inhibitors hepatitis c virus replication
|
|
GB0707000D0
(en)
*
|
2007-04-12 |
2007-05-30 |
Istituto Di Ricerche D Biolog |
Antiviral agents
|
|
WO2008148010A1
(en)
|
2007-05-23 |
2008-12-04 |
Vgx Pharmaceuticals, Inc. |
Composition comprising high concentration of biologically active molecules and processes for preparing the same
|
|
US7728027B2
(en)
|
2007-08-08 |
2010-06-01 |
Bristol-Myers Squibb Company |
Process for synthesizing compounds useful for treating hepatitis C
|
|
WO2009023179A2
(en)
|
2007-08-10 |
2009-02-19 |
Genelabs Technologies, Inc. |
Nitrogen containing bicyclic chemical entities for treating viral infections
|
|
WO2009032124A1
(en)
|
2007-08-29 |
2009-03-12 |
Schering Corporation |
Substituted indole derivatives and methods of use thereof
|
|
KR100903410B1
(ko)
|
2007-10-16 |
2009-06-18 |
(주)다산알앤디 |
자동속도조절 러닝머신 및 그 제어모듈
|
|
CN102317285A
(zh)
|
2007-11-16 |
2012-01-11 |
先灵公司 |
3-氨基磺酰基取代的吲哚衍生物及其使用方法
|
|
US8147818B2
(en)
|
2008-02-13 |
2012-04-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US7704992B2
(en)
|
2008-02-13 |
2010-04-27 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
AU2009214194B2
(en)
*
|
2008-02-14 |
2012-05-17 |
F. Hoffmann-La Roche Ag |
Heterocyclic antiviral compounds
|
|
WO2009137493A1
(en)
|
2008-05-05 |
2009-11-12 |
Wyeth |
2-substituted benzofuran compounds to treat infection with hepatitis c virus
|
|
WO2009137500A1
(en)
*
|
2008-05-05 |
2009-11-12 |
Wyeth |
6-substituted benzofuran compounds to treat infection with hepatitis c virus
|
|
CN101635673B
(zh)
|
2008-07-25 |
2012-01-25 |
华为技术有限公司 |
预订路径的方法、系统及路径计算客户、路径计算单元
|
|
US7906655B2
(en)
|
2008-08-07 |
2011-03-15 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US8048887B2
(en)
|
2008-09-11 |
2011-11-01 |
Bristol-Myers Squibb Company |
Compounds for the treatment of hepatitis C
|
|
US7994171B2
(en)
|
2008-09-11 |
2011-08-09 |
Bristol-Myers Squibb Company |
Compounds for the treatment of hepatitis C
|
|
US8198449B2
(en)
|
2008-09-11 |
2012-06-12 |
Bristol-Myers Squibb Company |
Compounds for the treatment of hepatitis C
|
|
US8293909B2
(en)
|
2008-09-11 |
2012-10-23 |
Bristol-Myers Squibb Company |
Compounds for the treatment of hepatitis C
|
|
JP2010092550A
(ja)
|
2008-10-09 |
2010-04-22 |
Hitachi Global Storage Technologies Netherlands Bv |
磁気記録ヘッド、その製造方法及び磁気記録再生装置
|
|
WO2010062821A1
(en)
|
2008-11-28 |
2010-06-03 |
Glaxosmithkline Llc |
Anti-viral compounds, compositions, and methods of use
|
|
MX2011005896A
(es)
|
2008-12-03 |
2011-09-29 |
Presidio Pharmaceuticals Inc |
Inhibidores de hcv ns5a.
|
|
RU2505539C2
(ru)
|
2008-12-23 |
2014-01-27 |
Эбботт Лэборетриз |
Антивирусные соединения
|
|
TWI438200B
(zh)
|
2009-02-17 |
2014-05-21 |
必治妥美雅史谷比公司 |
Ｃ型肝炎病毒抑制劑
|
|
WO2010096462A1
(en)
|
2009-02-17 |
2010-08-26 |
Enanta Pharmaceuticals, Inc |
Linked diimidazole derivatives
|
|
UY32462A
(es)
|
2009-02-23 |
2010-09-30 |
Arrow Therapeutics Ltd |
Derivados de bifenilo novedosos para el tratamiento de infección por virus de hepatitis c 644
|
|
WO2010099166A1
(en)
|
2009-02-27 |
2010-09-02 |
Siga Technologies, Inc. |
Thienopyridine derivatives for the treatment and prevention of dengue virus infections
|
|
EP2432554A1
(en)
|
2009-05-20 |
2012-03-28 |
F. Hoffmann-La Roche AG |
Heterocyclic antiviral compounds
|
|
CA2785488A1
(en)
*
|
2009-12-22 |
2011-07-21 |
Merck Sharp & Dohme Corp. |
Fused tricyclic compounds and methods of use thereof for the treatment of viral diseases
|
|
WO2011103063A1
(en)
|
2010-02-19 |
2011-08-25 |
Glaxo Group Limited |
Therapeutic compounds
|
|
WO2011106986A1
(en)
|
2010-03-02 |
2011-09-09 |
Merck Sharp & Dohme Corp. |
Inhibitors of hepatitis c virus ns5b polymerase
|
|
WO2011106929A1
(en)
|
2010-03-02 |
2011-09-09 |
Merck Sharp & Dohme Corp. |
Inhibitors of hepatitis c virus ns5b polymerase
|
|
AR080433A1
(es)
|
2010-03-02 |
2012-04-11 |
Merck Sharp & Dohme |
Derivados de benzofurancarboxamidas utiles para tratar o prevenir infecciones por vhc y composiciones farmaceuticas que los contienen.
|
|
AR080676A1
(es)
*
|
2010-03-09 |
2012-05-02 |
Schering Corp |
Compuestos de sililo triciclicos fusionados y metodos de uso de los mismos para el tratamiento de enfermedades virales
|
|
JP5572725B2
(ja)
|
2010-03-10 |
2014-08-13 |
ブリストル−マイヤーズ スクイブ カンパニー |
Ｃ型肝炎の処置のための化合物
|
|
US8354410B2
(en)
|
2010-03-11 |
2013-01-15 |
Bristol-Meyers Squibb Company |
Compounds for the treatment of hepatitis C
|
|
EP2545042A1
(en)
|
2010-03-11 |
2013-01-16 |
Bristol-Myers Squibb Company |
Compounds for the treatment of hepatitis c
|
|
AR082453A1
(es)
*
|
2010-04-21 |
2012-12-12 |
Novartis Ag |
Compuestos de furopiridina, composiciones farmaceuticas que los contienen y usos de los mismos
|
|
NZ609564A
(en)
|
2010-10-26 |
2015-06-26 |
Presidio Pharmaceuticals Inc |
Inhibitors of hepatitis c virus
|
|
WO2013163466A1
(en)
*
|
2012-04-25 |
2013-10-31 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of hepatitis c virus
|
